Equities

Sinocelltech Group Ltd

688520:SHH

Sinocelltech Group Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (CNY)43.40
  • Today's Change2.31 / 5.62%
  • Shares traded9.55m
  • 1 Year change-13.72%
  • Beta--
Data delayed at least 15 minutes, as of Nov 12 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of CNY
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
ASSETS
Cash And Short Term Investments293972349
Total Receivables, Net469297100
Total Inventory20319290
Prepaid expenses957048
Other current assets, total----3.42
Total current assets1,0601,531591
Property, plant & equipment, net1,3961,080707
Goodwill, net------
Intangibles, net18812235
Long term investments------
Note receivable - long term------
Other long term assets0.691.8140
Total assets2,7192,7361,373
LIABILITIES
Accounts payable116189135
Accrued expenses11816575
Notes payable/short-term debt1,008508281
Current portion long-term debt/capital leases51340790
Other current liabilities, total27110486
Total current liabilities2,0261,372668
Total long term debt1,093739705
Total debt2,6131,6541,076
Deferred income tax------
Minority interest(6.35)(5.54)(4.48)
Other liabilities, total205867232
Total liabilities3,3182,9731,600
SHAREHOLDERS EQUITY
Common stock445445435
Additional paid-in capital2,8822,8482,350
Retained earnings (accumulated deficit)(3926)(3530)(3011)
Treasury stock - common------
Unrealized gain (loss)------
Other equity, total(0.03)----
Total equity(599)(237)(227)
Total liabilities & shareholders' equity2,7192,7361,373
Total common shares outstanding445445435
Treasury shares - common primary issue000
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.